Clinical Trial Update: Terlipressin in Cirrhotic Patients With Recidivation Ascites Treated With Paracentesis and Albumin [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update shows terlipressin in cirrhotic patients with recurrent ascites treated with paracentesis and albumin has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis

Drugs mentioned

• Terlipressin (terlipressin)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Cirrhosis | Phase 3 | Status: COMPLETED